What insurance policy changes affect code H93.19?

There are 5 tracked policy changes affecting code H93.19, including updates from Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code H93.19?

Payers that have issued tracked updates for code H93.19 include: Aetna.

How do I get notified when code H93.19 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code H93.19. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code H93.19?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

H93.19 Insurance Policy Changes

ICD-10 H93.19 is officially defined as "Tinnitus, unspecified ear." code H93.19 is referenced in 5 tracked payer policy changes from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code H93.19 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Oct 26, 2026Medium impact
Pulsed Radiofrequency (CPB 0735, reviewed 2026-10-21)
Aetna's Clinical Policy Bulletin 0735 considers pulsed radiofrequency experimental, investigational, or unproven for all indications in its list, because its effectiveness has not been established. The list includes indications such as carpal tunnel syndrome, chronic knee pain, low back pain, trigeminal neuralgia, and headache. The policy also considers the Stimpod NMS460 nerve stimulator for post-amputation pain, combined ganglion impar block and pulsed radiofrequency for pudendal neuralgia, and combined platelet-rich plasma to the Gasserian ganglion and pulsed radiofrequency for trigeminal neuralgia experimental, investigational, or unproven.
Aetna · Identified Aug 18, 2026Medium impact
Tinnitus Treatments (CPB 0406, reviewed 2026-07-10)
Aetna considers cognitive behavioral therapy medically necessary for tinnitus when the tinnitus persists for 6 months or more, treatable causes such as cerumen impaction, ear infection, vascular pathology, ototoxic medications, Meniere's disease and acoustic neuroma have been ruled out, the tinnitus causes clinically significant distress or functional impairment, and a licensed mental health professional trained in CBT delivers the therapy. Cortical mastoidectomy with restoration of separation between the sigmoid sinus and middle ear is also considered medically necessary for tinnitus from a bony defect when a sigmoid sinus dehiscence is documented on temporal bone imaging. Tinnitus instruments such as maskers and hearing aids are considered experimental, investigational, or unproven, along with a list of other tinnitus interventions that includes acupuncture, cochlear implants, TENS, transcranial magnetic stimulation and vagus nerve stimulation.
Aetna · Identified Aug 14, 2026Medium impact
Epidural Injection Technologies (CPB 0934, reviewed 2025-04-08)
As last reviewed on April 8, 2025, Aetna considers epidural blood patching medically necessary for post-dural puncture headache lasting longer than 24 hours, and for spontaneous intracranial hypotension with orthostatic headache lasting more than 2 weeks when brain MRI shows dural enhancement or spinal imaging shows epidural CSF collection or a CSF leak site. Repeat patching is covered when the first patch does not give prolonged relief and additional spinal imaging identifies a CSF leak site, and transforaminal patching is covered for post-dural puncture headache when the interlaminar approach was ineffective. Prophylactic patching, patching for post-dural puncture tinnitus, epidural fibrin glue or platelet-rich plasma patching for post-dural puncture headache, and real-time pressure-sensing epidural guidance are experimental, investigational or unproven.
Aetna · Identified Aug 14, 2026Medium impact
Eagle's and Ernest Syndrome (CPB 0400, reviewed 2026-06-30)
Aetna's Clinical Policy Bulletin 0400 considers styloidectomy medically necessary for Eagle's syndrome only when specific criteria are met, with separate criteria for the non-vascular form and the vascular form linked to carotid artery dissection. Radiofrequency thermoneurolysis is considered experimental, investigational or unproven for Eagle's and Ernest syndromes, and styloidectomy for jugular vein stenosis, for carotid stenosis without dissection, and for other listed indications such as tinnitus, headache and neck pain is also considered experimental, investigational or unproven.
Aetna · Identified Aug 12, 2026Medium impact
Biofeedback (CPB 0132, reviewed 2026-07-16)
Aetna considers biofeedback medically necessary for cancer pain, chronic constipation secondary to dyssynergic defecation as confirmed by anorectal manometry, fecal incontinence, irritable bowel syndrome, levator ani syndrome, migraine and tension headaches, refractory severe subjective tinnitus, temporomandibular joint syndrome, urinary incontinence, and neuromuscular rehabilitation of stroke and traumatic brain injury. Biofeedback is considered not medically necessary when used to improve emotional and physical health in non-diseased persons. EEG biofeedback is considered experimental, investigational, or unproven for migraine and tension headache, and several listed uses are experimental, including amygdala-related EEG neurofeedback for PTSD, HeartMath HRV biofeedback for headaches, InTandem for walking in chronic stroke, and surface EMG biofeedback for chronic ankle instability. Some Aetna plans exclude coverage of biofeedback.

Watch H93.19

Get one email when a payer policy names H93.19, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Pulsed Radiofrequency (CPB 0735, reviewed 2026-10-21)

Tinnitus Treatments (CPB 0406, reviewed 2026-07-10)

Epidural Injection Technologies (CPB 0934, reviewed 2025-04-08)

Eagle's and Ernest Syndrome (CPB 0400, reviewed 2026-06-30)

Biofeedback (CPB 0132, reviewed 2026-07-16)

What insurance policy changes affect code H93.19?

Which payers have updated policy for code H93.19?

How do I get notified when code H93.19 policy changes?

Why do payers change policies for code H93.19?